Market Place
Sourcing Support
As Sandoz contract winds down, GSK will close antibiotics plant in UK
10 Sep 2024 //
FIERCE PHARMA
Debt-free Orchid Pharma charts out growth plan
24 Apr 2024 //
ECONOMICTIMES
Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
11 Jul 2023 //
ECONOMIC TIMES
Venus Remedies gets good manufacturing certification from Saudi drug regulator
27 Feb 2023 //
ECONOMIC TIMES
IPC flags safety alert against dimethyl fumarate & cefazolin
14 Oct 2021 //
PHARMABIZ
Sandoz completes acquisition of GSK’s cephalosporin business
11 Oct 2021 //
PMLIVE
Lincoln Pharma plans to launch cephalosporin products
21 Sep 2021 //
PHARMABIZ
FDA gets specific on data integrity rules; Lupin, Dishman tagged with 483s
14 Dec 2018 //
FIERCE PHARMA
US FDA completes inspection of Lupin’s Mandideep location
13 Dec 2018 //
PRESS RELEASE
USFDA makes 22 observations post inspection of Lupin`s Mandideep facilities
06 Dec 2018 //
ECONOMIC TIMES
Conspiracy to Defame Indian Pharma Globally is on: Pharmexcil
27 Oct 2016 //
ECONOMIC TIMES
Anvisa releases import of inputs of Orchid Chemicals company
26 Jan 2016 //
ANVISA
Resistance to last-resort antibiotic has now spread across globe
08 Dec 2015 //
NEW SCIENTIST
Aurobindo Pharma to expand product basket; eyes $3 billion revenues by FY18
25 Aug 2015 //
THE ECONOMIC TIMES
Nectar Lifesciences Ltd. bags ANVISA (Brazil) cGMP for Cephalosporin API’s manufacturing facility
14 May 2015 //
MONEYCONTROL.COM
Anvisa Suspends Imports of all Beta-lactam Cephalosporin from Lupin Limited
13 May 2015 //
ANVISA
How Marketing Exclusivity Led to Higher Drug Costs and Questionable Benefits
06 May 2015 //
PHARMALOT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.